A detailed history of Teacher Retirement System Of Texas transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 335,013 shares of GILD stock, worth $30.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
335,013
Previous 286,920 16.76%
Holding current value
$30.2 Million
Previous $19.7 Million 42.64%
% of portfolio
0.14%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $3.2 Million - $4.04 Million
48,093 Added 16.76%
335,013 $28.1 Million
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $226,771 - $261,712
3,591 Added 1.27%
286,920 $19.7 Million
Q1 2024

May 06, 2024

SELL
$71.58 - $87.29 $585,023 - $713,421
-8,173 Reduced 2.8%
283,329 $20.8 Million
Q4 2023

Feb 07, 2024

SELL
$73.27 - $83.09 $2.83 Million - $3.21 Million
-38,658 Reduced 11.71%
291,502 $23.6 Million
Q3 2023

Oct 31, 2023

BUY
$73.94 - $80.67 $370,735 - $404,479
5,014 Added 1.54%
330,160 $24.7 Million
Q2 2023

Jul 19, 2023

SELL
$76.01 - $86.7 $1.81 Million - $2.06 Million
-23,791 Reduced 6.82%
325,146 $25.1 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $9.1 Million - $10.4 Million
-117,704 Reduced 25.22%
348,937 $29 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $5.73 Million - $8.23 Million
-92,008 Reduced 16.47%
466,641 $40.1 Million
Q3 2022

Nov 03, 2022

BUY
$59.54 - $68.01 $3.28 Million - $3.75 Million
55,092 Added 10.94%
558,649 $34.5 Million
Q2 2022

Aug 09, 2022

SELL
$57.72 - $65.01 $29.3 Million - $33 Million
-507,455 Reduced 50.19%
503,557 $31.1 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $6.77 Million - $8.48 Million
116,902 Added 13.07%
1,011,012 $60.1 Million
Q4 2021

Feb 10, 2022

BUY
$64.88 - $73.64 $5.94 Million - $6.74 Million
91,563 Added 11.41%
894,110 $64.9 Million
Q3 2021

Nov 09, 2021

SELL
$67.69 - $73.03 $16.6 Million - $17.9 Million
-245,155 Reduced 23.4%
802,547 $56.1 Million
Q2 2021

Aug 05, 2021

BUY
$63.47 - $69.35 $30.2 Million - $33 Million
476,173 Added 83.32%
1,047,702 $72.1 Million
Q1 2021

May 11, 2021

BUY
$60.0 - $68.46 $3.48 Million - $3.97 Million
57,941 Added 11.28%
571,529 $36.9 Million
Q4 2020

Feb 11, 2021

SELL
$56.65 - $64.55 $20.3 Million - $23.1 Million
-358,534 Reduced 41.11%
513,588 $29.9 Million
Q3 2020

Nov 02, 2020

BUY
$62.1 - $78.08 $7.68 Million - $9.66 Million
123,707 Added 16.53%
872,122 $55.1 Million
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $40.1 Million - $46.6 Million
554,267 Added 285.49%
748,415 $57.6 Million
Q1 2020

May 05, 2020

SELL
$62.63 - $80.22 $36.8 Million - $47.1 Million
-586,850 Reduced 75.14%
194,148 $14.5 Million
Q4 2019

Feb 06, 2020

SELL
$61.62 - $67.78 $1.31 Million - $1.44 Million
-21,256 Reduced 2.65%
780,998 $50.7 Million
Q3 2019

Oct 28, 2019

BUY
$62.51 - $69.0 $13.4 Million - $14.8 Million
214,317 Added 36.45%
802,254 $50.8 Million
Q2 2019

Aug 05, 2019

SELL
$61.87 - $69.38 $2.18 Million - $2.44 Million
-35,218 Reduced 5.65%
587,937 $39.7 Million
Q1 2019

May 06, 2019

SELL
$62.53 - $70.05 $4.47 Million - $5 Million
-71,437 Reduced 10.28%
623,155 $40.5 Million
Q4 2018

Mar 04, 2019

SELL
$60.54 - $79.0 $2.4 Million - $3.13 Million
-39,607 Reduced 5.39%
694,592 $43.4 Million
Q3 2018

Nov 09, 2018

SELL
$71.28 - $78.92 $23.4 Million - $25.9 Million
-328,720 Reduced 30.93%
734,199 $56.7 Million
Q2 2018

Aug 06, 2018

BUY
$64.88 - $75.68 $1.71 Million - $1.99 Million
26,294 Added 2.54%
1,062,919 $75.3 Million
Q1 2018

May 08, 2018

SELL
$72.84 - $88.8 $19.3 Million - $23.5 Million
-264,428 Reduced 20.32%
1,036,625 $78.2 Million
Q4 2017

Feb 06, 2018

BUY
$71.15 - $83.52 $30 Million - $35.2 Million
421,437 Added 47.91%
1,301,053 $93.2 Million
Q3 2017

Nov 06, 2017

BUY
$72.11 - $85.47 $63.4 Million - $75.2 Million
879,616
879,616 $71.3 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.